BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3784449)

  • 1. Studies on haematocrit in peripheral arterial disease.
    Lowe GD; Saniabadi A; Turner A; Lieberman P; Pollock J; Drury J
    Klin Wochenschr; 1986 Oct; 64(19):969-74. PubMed ID: 3784449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of venesection on leg blood flow in claudicants with high-normal haematocrit.
    Turner AR; Lowe GD; Forbes CD; Pollock JG
    Scott Med J; 1988 Aug; 33(4):298-9. PubMed ID: 3187499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.
    Smith FB; Connor JM; Lee AJ; Cooke A; Lowe GD; Rumley A; Fowkes FG
    Thromb Res; 2003; 112(4):209-16. PubMed ID: 14987913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemorrheological modifications during normal pregnancy].
    Huisman A
    Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):143-7. PubMed ID: 1767164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorrheologic disorders in obese patients. Study of the viscosity of the blood, erythrocytes, plasma, fibrinogen and the erythrocyte filtration index].
    Craveri A; Tornaghi G; Paganardi L; Ranieri R; Leonardi G; Di Bella M
    Minerva Med; 1987 Jul; 78(13):899-906. PubMed ID: 3601135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels with cigarette smokers.
    Dintenfass L
    Med J Aust; 1975 May; 1(20):617-20. PubMed ID: 1143159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the relationship of plasma fibrinogen, platelet aggregation rate and peripheral arterial occlusive disease].
    Wang J; Li XY; He Y; Ni B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jan; 26(1):1-4. PubMed ID: 15921581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
    van der Loo B; Kovacevic T; Krieger E; Banyai S; Banyai M; Amann-Vesti BR; Jagacic D; Rousson V; Koppensteiner R
    Clin Hemorheol Microcirc; 2005; 32(2):159-68. PubMed ID: 15764824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation and blood rheology in severe sepsis/septic shock: relation to the Sepsis-related Organ Failure Assessment (SOFA) score.
    Alt E; Amann-Vesti BR; Madl C; Funk G; Koppensteiner R
    Clin Hemorheol Microcirc; 2004; 30(2):107-15. PubMed ID: 15004335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets' glycoproteins and their ligands in patients with intermittent claudication.
    Gosk-Bierska I; Adamiec R; Szuba A
    Int Angiol; 2003 Jun; 22(2):164-71. PubMed ID: 12865882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease.
    Vigilance JE; Reid HL
    J Diabetes Complications; 2008; 22(3):210-6. PubMed ID: 18413225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty.
    Késmárky G; Tóth K; Vajda G; Habon L; Halmosi R; Róth E
    Clin Hemorheol Microcirc; 2001; 24(1):33-41. PubMed ID: 11345232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication.
    Panchenko E; Dobrovolsky A; Rogoza A; Sorokin E; Ageeva N; Markova L; Titaeva E; Anuchin V; Karpov Y; Saks V
    Int Angiol; 1994 Mar; 13(1):59-64. PubMed ID: 8077800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease.
    Lee AJ; Fowkes FG; Rattray A; Rumley A; Lowe GD
    Br J Haematol; 1996 Jan; 92(1):226-30. PubMed ID: 8562400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers.
    Belch JJ; McArdle BM; Burns P; Lowe GD; Forbes CD
    Thromb Haemost; 1984 Feb; 51(1):6-8. PubMed ID: 6232729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
    Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relation between erythrocyte filterability and platelet aggregation (in vitro studies in normal subjects and those with vascular disease before and after isotonic exercise)].
    Guerrini M; Vittoria A; Pieragalli D; Acciavatti A; Del Bigo C; Martelli G; Franchi M; Messa G; Galigani C; Di Perri T
    Ric Clin Lab; 1983; 13 Suppl 3():309-14. PubMed ID: 6231712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.